ResearcherStatens Serum InstitutNo recent work listed

Niels H. H. Heegaard

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5067728639, A5108359359. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune p… Co-author DOI 10.1097/md.0000000000011641 ↗
Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. Last author DOI 10.1097/mpa.0b013e318296bb34 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ove B. Schaffalitzky de Muckadell · 2 shared papers, 2013–2018 · strength 0.14
- Paper Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers… DOI 10.1097/md.0000000000011641 ↗
- Paper Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. DOI 10.1097/mpa.0b013e318296bb34 ↗
Claus Wilki Fristrup · 1 shared paper, 2018 · strength 0.10
- Paper Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers… DOI 10.1097/md.0000000000011641 ↗
Sönke Detlefsen · 1 shared paper, 2018 · strength 0.10
- Paper Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers… DOI 10.1097/md.0000000000011641 ↗
Anting Liu Carlsen · 1 shared paper, 2013 · strength 0.05
- Paper Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. DOI 10.1097/mpa.0b013e318296bb34 ↗
Maiken Thyregod Jøergensen · 1 shared paper, 2013 · strength 0.05
- Paper Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. DOI 10.1097/mpa.0b013e318296bb34 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.